Laurel Bernstein

Laurel Bernstein has a strong background in intellectual property, with experience in various roles throughout their career. Laurel is currently the VP of Intellectual Property at OmniAb, Inc. starting in November 2022. Prior to that, they worked at Ligand Pharmaceuticals as the Director of Intellectual Property from April 2018 to November 2022. From December 2006 to December 2016, they held the position of Executive Director of Intellectual Property at Lpath, Inc., where they were responsible for drafting and prosecuting patent applications and managing collaborations. Before that, they were the Executive Director of Patents at Isis Pharmaceuticals, Inc. from 1991 to 2005, overseeing a large portfolio of patents and patent prosecution. Laurel began their career as a Postdoctoral Research Fellow at the Research Institute of Scripps Clinic from 1987 to 1991.

Laurel Bernstein holds a Doctor of Philosophy (Ph.D.) degree in Molecular and Cell Biology from Brown University. Prior to that, they obtained a Bachelor of Arts (B.A.) degree in Biology from the University of Virginia. In addition, they have a certification as a Registered Patent Agent from the USPTO. The specific years of completion for their degrees and the month and year they obtained their certification are not provided.